Showing results (161-170 of 525) with videos related to

Sort By:
Pageof 53
Early Human Development|May 2, 2015
Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter databasePatricia Y Chu, Kevin D Hill, Reese H Clark, et al.
Plos One|April 22, 2015
Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK CellsSudipta Tripathi, Lola Chabtini, Pranal J Dakle, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2008
Safety of placebo controls in pediatric hypertension trialsP Brian Smith, Jennifer S Li, M Dianne Murphy, et al.
Ecology and Evolution|April 10, 2026
Physiological Impacts of a Newly Discovered Trematode Parasite on Its Host, the Bay Scallop (Argopecten irradians)Hailea F H Boggess, Connor R Brainard, Brian Smith, et al.
Pediatrics|August 25, 2010
Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivitySara K Pasquali, Danielle S Burstein, Daniel K Benjamin, et al.
The Annals of Thoracic Surgery|August 14, 2002
Echocardiographic evidence of right ventricular remodeling after transplantationHolger K Eltzschig, Tomislav Mihaljevic, John G Byrne, et al.
American Journal of Perinatology|November 1, 2018
Trial Characteristics That Affect Parental Consent in Neonatal Drug TrialsI Blaire Hanvey, Sofia Aliaga, Matthew M Laughon, et al.
Infection Control and Hospital Epidemiology|February 19, 2009
Effect of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit on total hospital costEric D Schultz, David T Tanaka, Ronald N Goldberg, et al.
British Journal of Clinical Pharmacology|November 7, 2012
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspectiveJodi M Lestner, P Brian Smith, Michael Cohen-Wolkowiez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2007
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humansMingxin Qian, Stephen A Bai, Bernice Brogdon, et al.
Pageof 53